Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington, USA.
VA Health Services Research and Development Center for Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound Health Care System, Seattle, Washington, USA.
J Trauma Stress. 2023 Dec;36(6):1102-1114. doi: 10.1002/jts.22975. Epub 2023 Oct 16.
The PTSD Checklist for DSM-5 (PCL-5) is a measure of posttraumatic stress disorder (PTSD) symptom severity that is widely used for clinical and research purposes. Although previous work has examined metrics of minimal important difference (MID) of the PCL-5 in veteran samples, no work has identified PCL-5 MID metrics among adults in primary care in the United States. In this secondary analysis, data were evaluated from primary care patients (N = 971) who screened positive for PTSD and participated in a large clinical trial in federally qualified health centers in three U.S. states. Participants primarily self-identified as women (70.2%) and White (70.3%). We calculated test-retest reliability using clinic registry data and multiple distribution- and anchor-based metrics of MID using baseline and follow-up survey data. Test-retest reliability (Pearson's r, Spearman's ρ, intraclass correlation coefficient) ranged from adequate to excellent (.79-.94), with the shortest time lag demonstrating the highest reliability estimate. The MID for the PCL-5 was estimated using multiple approaches. Distribution-based approaches indicated an MID range of 8.5-12.5, and anchor-based approaches indicated an MID range of 9.8-11.7. Taken together, the MID metrics indicate that PCL-5 change scores of 9-12 likely reflect real change in PTSD symptoms and indicate at least an MID for patients, whereas PCL-5 change scores of 5 or less likely are not reliable. These findings can help inform clinicians using the PCL-5 in similar populations to track patient responses to treatment and help researchers interpret PCL-5 score changes in clinical trials.
创伤后应激障碍检查表第五版(PCL-5)是一种广泛用于临床和研究目的的创伤后应激障碍(PTSD)症状严重程度的测量工具。尽管之前的工作已经研究了退伍军人样本中 PCL-5 的最小有意义差异(MID)的指标,但没有工作在全美初级保健中的成年人中确定 PCL-5 的 MID 指标。在这项二次分析中,数据来自于在三个美国州的联邦合格健康中心参加大型临床试验的筛查出 PTSD 阳性的初级保健患者(N=971)。参与者主要是女性(70.2%)和白人(70.3%)。我们使用诊所登记数据计算了测试-重测信度,并使用基线和随访调查数据使用多种分布和基于锚定的 MID 指标进行了计算。测试-重测信度(Pearson r、Spearman ρ、组内相关系数)从适度到优秀不等(.79-.94),最短时间滞后的信度估计值最高。使用多种方法估计了 PCL-5 的 MID。基于分布的方法表明 MID 范围为 8.5-12.5,基于锚定的方法表明 MID 范围为 9.8-11.7。综上所述,MID 指标表明 PCL-5 的变化分数在 9-12 可能反映了 PTSD 症状的真实变化,表明患者至少有一个 MID,而 PCL-5 的变化分数为 5 或更低可能不可靠。这些发现可以帮助在类似人群中使用 PCL-5 的临床医生跟踪患者对治疗的反应,并帮助研究人员在临床试验中解释 PCL-5 评分的变化。